Abstract
Immunotherapy based on monocyte-derived dendritic cells (MDDCs) is a promising strategy for the treatment of HIV-infected individuals. Due to their remarkable plasticity, heterogeneous populations of MDDCs can be obtained in vitro, depending on the culture conditions. Consequently, the capacity of these cells to secrete cytokines and express molecules that participate in the antigenic pre…